SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-21-006211
Filing Date
2021-03-17
Accepted
2021-03-17 08:31:18
Documents
76
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm 10-K 1083677
2 ex23-1.htm EX-23.1 4761
3 ex31-1.htm EX-31.1 12876
4 ex31-2.htm EX-31.2 12867
5 ex32-1.htm EX-32.1 13244
  Complete submission text file 0001493152-21-006211.txt   4370539

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE cocp-20201231.xml EX-101.INS 581155
7 XBRL SCHEMA FILE cocp-20201231.xsd EX-101.SCH 59497
8 XBRL CALCULATION FILE cocp-20201231_cal.xml EX-101.CAL 60090
9 XBRL DEFINITION FILE cocp-20201231_def.xml EX-101.DEF 195148
10 XBRL LABEL FILE cocp-20201231_lab.xml EX-101.LAB 376095
11 XBRL PRESENTATION FILE cocp-20201231_pre.xml EX-101.PRE 292753
Mailing Address 19805 N. CREEK PARKWAY BOTHELL WA 98011
Business Address 19805 N. CREEK PARKWAY BOTHELL WA 98011 (786) 459-1831
Cocrystal Pharma, Inc. (Filer) CIK: 0001412486 (see all company filings)

IRS No.: 352528215 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38418 | Film No.: 21748504
SIC: 2834 Pharmaceutical Preparations